Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 234 (8%) | |
Anticipated shortage: | 20 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91094 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91097 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2021-10-08 | 2022-02-28 | 146907 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2021-10-29 | 2022-02-28 | 148509 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-02-04 | 2022-02-28 | 154184 |
APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2022-03-07 | 2022-07-15 | 156214 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-11-04 | 2022-12-05 | 173818 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2023-07-21 | 2024-03-01 | 199536 |
APO-OXAPROZIN | 600MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 411 |
APO-OXAZEPAM | 10MG | TABLET | Resolved | 2022-07-22 | 2022-09-23 | 165329 |
APO-OXCARBAZEPINE | 600MG | TABLET | Resolved | 2020-06-10 | 2022-02-09 | 117395 |
APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118043 |
APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118046 |
APO-OXCARBAZEPINE | 600MG | TABLET | Resolved | 2022-03-25 | 2022-05-25 | 157311 |
APO-OXCARBAZEPINE | 150MG | TABLET | Actual shortage | 2024-02-09 | 2024-04-12 | 219159 |
APO-OXCARBAZEPINE | 300MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-12 | 224598 |
APO-OXYBUTYNIN | 1MG | SYRUP | Actual shortage | 2017-08-13 | 2017-10-05 | 19045 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2022-12-23 | 2023-01-26 | 179456 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-27 | 183474 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187229 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |